Status:
WITHDRAWN
Acamprosate for Treatment of Compulsive Behaviors and Craving in Parkinson's Disease
Lead Sponsor:
Baylor College of Medicine
Collaborating Sponsors:
National Parkinson Foundation
Conditions:
Parkinson's Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine how many patients with Parkinson's disease have compulsive behaviors, and what types of behaviors they have. This study will also determine if acamprosate can...
Eligibility Criteria
Inclusion
- Idiopathic Parkinson's disease
- Active dopaminergic therapy at stable dose for one month (levodopa or dopamine agonist)
- Able and willing to complete Rating Scales
- Presence of one or more compulsive behavior based on responses to Rating Scales (defined as \>5 on the SOGS; \>17 on the YBOCS-SV and YBOCS-CUV; \>1.7 on the SCS for women and \>2.1 on the SCS for men; \>15 on the YBOCS-BE, \>5.5 on the CQ).
- Written informed consent
- Inclusion criteria (controls):
- No significant psychiatric disease
- Able and willing to complete Rating Scales
- Written informed consent
Exclusion
- No anticipated need for adjustment of medications for Parkinson's disease
- Current participation in another clinical study
- History of unstable psychiatric disease (as determined by the Principal Investigator)
- Women of childbearing age not using appropriate contraceptive methods (oral contraceptives, condoms, surgery)
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00640952
Start Date
August 1 2006
End Date
September 1 2008
Last Update
November 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PDCMDC 6550 Fannin, Suite 1801
Houston, Texas, United States, 77030